In 2024, we're facing a rapidly evolving landscape of technologies that have been put into motion to solve a new category of problems. One such area is 'Drug Repurposing.'

The last few decades have resulted in an explosion of experimental and clinical data from sources all over the world. However, limitations in our analytical and information-processing bandwidth have resulted in potentially impactful discoveries remaining hidden.

The genesis of drug repurposing is not in this newfound ability, however, AI has effectively placed us in the arena where the qualitative assessment of large troves of published scientific literature is possible. This can highlight connections between disease and drug mechanisms that remained unidentified or underappreciated.

AI models are now being leveraged to recommend drugs for indications as potential therapies or cures. To learn more about our work in this field click below.

In early 2024, we started consulting for a team of scientists at Boston College and the CEA (France). Having developed a potentially groundbreaking technology with immediate implications in pharmaceutical drug discovery methods. To help the group realize the potential we started working with them to conceptualize real-world applications of the algorithm in biomedical research.

Our involvement in this ongoing project has thus far facilitated the approval of grant money by the CEA to continue developing the technology. For more on the work click here...

Our organization is effectively positioned to provide consulting services for different areas within medical education.

Our mission is to enhance the quality of medical education by introducing and integrating emerging technologies that can improve both didactic and clinical educational settings. We want high-quality resources available to every student across the world and work with clients to cater to the specific needs of their institution.

We not only offer admissions consulting to aspiring medical students across the world (specifically to gain admission to MD/DO programs in the United States) but also help medical schools with accreditation consulting.

We rely on our consultants with experience in managing admissions, medical school administration, medical education, and accreditation efforts to maximize chances of success.

Among the multiple ongoing projects in this sector, a major effort is dedicated to facilitating the process of completing documentation, upgrading facilities, hiring faculty, and starting programs needed for CAAM-HP accreditation. The results of one of these projects and the achieved milestones will be published here in November 2024.

For more information, visit the link below...